When browsing #opioid industry documents, you may come across unfamiliar acronyms. To help researchers, we’ve started a glossary. We hope it helps—and if you find an acronym not listed, let us know! https://www.industrydocuments.ucsf.edu/opioids/research-tools/acronym-glossary/

Itt a vakcina, amely megakadályozhatja az Észak-Amerikában százezrek halálát okozó opioidok túladagolását A heroinnál százszor durvább szintetikus opioidok használata jelentős társadalmi problémát jelent Kanadában és az USA-ban. https://qubit.hu/2023/09/11/itt-a-vakcina-amely-megakadalyozhatja-az-eszak-amerikaban-szazezrek-halalat-okozo-opioidok-tuladagolasat #opioid-járvány #opioid-krízis

Researchers use stem cells to generate human neurons resembling those in the brain that control breathing during opioid reactions, for eventual chip devices to test overdose therapies.

https://sciencebusiness.technewslit.com/?p=45185

#News #Press #Science #Business #Opioid #Overdose #Preclinical #Toxicity #Neurons #Breathing #Naloxone #Fentanyl #Codeine #Brain #Methadone #StemCells #Biotechnology #Engineering #Chemistry

#Kroger will pay up to $1.2 billion to #settle most nationwide #opioid claims

https://ground.news/article/kroger-will-pay-up-to-12-billion-to-settle-most-nationwide-opioid-claims

State unemployment benefits moderate the link between job loss and county opioid overdose death rates. #NICHDImpact #Unemployment #JobLoss #Opioid #Overdose
https://www.ncbi.nlm.nih.gov/pubmed/35212718

Experts now warn that the threat posed by #fentanyl may ultimately pale in comparison to the emergence of an even more dangerous type of synthetic #opioid that's now tainting the illegal drug supply: #nitazenes...
https://www.upi.com/Health_News/2023/09/05/nitazenes-opioids-illicit-drug/7921693929764/?s=09

This leaves liberals in the increasingly absurd position of defending the indefensible: insisting that the #FDA shouldn't be questioned despite its ghastly failures during the #opioid epidemic; claiming that the #VotingMachine companies whose defective products have been the source of increasingly urgent technical criticism are without flaw.

9/

We posted 15,000+ new Insys Therapeutics documents to our #Opioid Industry Documents #Archive yesterday! Emails, reports & documents from 2014 discussing the many aspects of Insys's business activities, ranging from sales to speakers bureau training. https://www.industrydocuments.ucsf.edu/opioids/collections/insys-litigation-documents/

Not sure where to start w/ the #Opioid Industry Documents Archive? We crafted a page to provide users w/ helpful tips, resources & docs to get you started! Drop by & explore our "New to the Archive?" intro page and let us know if you find it helpful:
https://www.industrydocuments.ucsf.edu/opioids/research-tools/new-to-the-archive/

@riteaid plans #bankruptcy in legal manoever to avoid #opioid lawsuits
https://www.wsj.com/articles/rite-aid-prepares-bankruptcy-that-would-halt-opioid-lawsuits-69f94242

Nice op-ed from California assemblyman and veteran @DevonMathis about holding accountable companies that profited from #opioid addiction. The piece links to info on the McKinsey documents in OIDA, and to a @WSJ piece about McKinsey's role in pharma marketing to the VA that cited OIDA docs. https://www.sacbee.com/opinion/op-ed/article278490329.html

Database shows #opioid epidemic deaths high in #Baltimore

https://www.wbaltv.com/article/opioid-epidemic-database-baltimore-deaths/44869671

#maryland #md #drugs

Why is it so hard to create new types of #painrelievers?
As the #opioid crisis rages, companies are on a hunt for new, nonaddictive #pain #medicines. A new study by Boston-based biotech #Vertex may be making headway with its compound #VX548, a pill that aims to relieve pain in wake of surgery. Highest dose of compound offered greater pain relief than placebo after bunion removal or tummy tuck. That’s good news in a space that has had more than its fair share of setbacks. https://www.technologyreview.com/2023/08/11/1077750/why-is-it-so-hard-to-create-new-types-of-pain-relievers/

#SupremeCourt blocks $6 billion #PurduePharma #opioid settlement and will hear case this fall

https://flip.it/iHUYjQ

In northern #NH, the #opioid crisis is getting worse. Communities are searching for answers — and more attention...
https://www.nhpr.org/health/2023-08-09/coos-county-addiction-recovery-colebrook-pittsburg-berlin
"Police Chief Paul Rella says the #fentanyl crisis came late to #Colebrook, but it’s now in full force. He says he gets regular calls about discarded needles and drug use in public bathrooms. Last year, five people died of #overdoses in Colebrook alone — one for every 400 residents."

‘Using bankruptcy initially as a shield and now as a sword’…to avoid paying back for your opioid pushing misdeeds

Why do I call them $MalignRot?

https://podcasts.apple.com/ca/podcast/the-journal/id1469394914?i=1000622969446

When even the WSJ calls their actions ‘cynical’….see this as a roadmap for other companies to squeeze out of the #opioid settlements

Americans: Don’t blame China for your opioid crisis - blame your corporate Pharma, the lawyers & the hedge fund profiteers #Mallinckrodt #MalignRot

FDA approves nonprofit's over-the-counter opioid overdose nasal spray used to reverse opioid overdose

RiVive, made by Harm Reduction Therapeutics, is the second #nonprescription #naloxone product the FDA has approved.

But unlike other opioid overdose products, the 3 milligram treatment will be available for free or low cost, and its sales will bring no profit to its manufacturer

#DrugOverDose #Health #FDA #Opioid #nonProfit #RiVive #NoProfit

🔗 https://www.wcpo.com/fda-approves-nonprofit-s-over-the-counter-opioid-overdose-nasal-spray

Good article on dealing with myths about #opioid use disorder, backed by #research articles for your #science reading pleasure.

https://limestonepostmagazine.com/myths-persist-about-people-with-opioid-use-disorder/

Republished from @TheConversationUS , but using this link as Conversation's url link is HUGE!! 🙃

New paper alert!
Gac, Yakubi & Apollonio -'Issues arising from the study design, conduct, & promotion of #clinicaltrials funded by #opioid manufacturers: a review of internal pharmaceutical industry documents' - https://doi.org/10.1332/174426421X16856230946027

#opioidepidemic #OIDA #Archives

Dr. Jeremy Greene's quote is from our June 2022 announcement of the addition of the McKinsey documents to OIDA, but it speaks to the importance of all the #opioid documents and could be extended to all of our #industrydocs. https://hub.jhu.edu/2022/06/30/mckinsey-opioid-documents-archive